Ellen Rafferty

776 total citations
37 papers, 460 citations indexed

About

Ellen Rafferty is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Ellen Rafferty has authored 37 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Infectious Diseases and 12 papers in Health. Recurrent topics in Ellen Rafferty's work include Vaccine Coverage and Hesitancy (12 papers), Influenza Virus Research Studies (5 papers) and Animal Disease Management and Epidemiology (5 papers). Ellen Rafferty is often cited by papers focused on Vaccine Coverage and Hesitancy (12 papers), Influenza Virus Research Studies (5 papers) and Animal Disease Management and Epidemiology (5 papers). Ellen Rafferty collaborates with scholars based in Canada, United States and Rwanda. Ellen Rafferty's co-authors include Shannon E. MacDonald, Marwa Farag, Manish Sadarangani, Lawrence W. Svenson, Janna M. Schurer, Joan Robinson, Mohsen Yaghoubi, Jeff Taylor, Julie A. Bettinger and Caroline Quach and has published in prestigious journals such as PLoS ONE, Environmental Health Perspectives and BMC Public Health.

In The Last Decade

Ellen Rafferty

37 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Rafferty Canada 14 169 120 114 68 57 37 460
Tarik Derrough Sweden 13 327 1.9× 164 1.4× 152 1.3× 54 0.8× 62 1.1× 24 535
Rui G. Vaz Nigeria 17 160 0.9× 251 2.1× 108 0.9× 48 0.7× 70 1.2× 40 648
Nancy A. Otieno Kenya 12 294 1.7× 121 1.0× 134 1.2× 88 1.3× 55 1.0× 43 527
Shainoor J. Ismail Canada 11 159 0.9× 124 1.0× 196 1.7× 28 0.4× 40 0.7× 27 366
Masahiko Hachiya Japan 14 210 1.2× 158 1.3× 216 1.9× 74 1.1× 53 0.9× 51 537
Ahmed R. Alsuwaidi United Arab Emirates 15 248 1.5× 262 2.2× 149 1.3× 34 0.5× 65 1.1× 46 627
Pablo Kuri Mexico 12 165 1.0× 124 1.0× 73 0.6× 100 1.5× 40 0.7× 22 441
W. William Schluter United States 13 195 1.2× 164 1.4× 111 1.0× 124 1.8× 28 0.5× 26 436
Martin O. C. Ota Belgium 10 148 0.9× 122 1.0× 188 1.6× 170 2.5× 56 1.0× 15 594
Chizoba Wonodi United States 14 284 1.7× 132 1.1× 260 2.3× 54 0.8× 74 1.3× 40 634

Countries citing papers authored by Ellen Rafferty

Since Specialization
Citations

This map shows the geographic impact of Ellen Rafferty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Rafferty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Rafferty more than expected).

Fields of papers citing papers by Ellen Rafferty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Rafferty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Rafferty. The network helps show where Ellen Rafferty may publish in the future.

Co-authorship network of co-authors of Ellen Rafferty

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Rafferty. A scholar is included among the top collaborators of Ellen Rafferty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Rafferty. Ellen Rafferty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rafferty, Ellen, et al.. (2024). Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials. Open Forum Infectious Diseases. 11(5). 9 indexed citations
2.
Rafferty, Ellen, et al.. (2023). Healthcare costs and effects of post-COVID-19 condition in Canada. Canada Communicable Disease Report. 49(10). 425–432. 1 indexed citations
3.
Schurer, Janna M., et al.. (2023). “I sold my towel and shoes to pay the traditional healer”: Care-seeking costs and productivity losses among snakebite victims in Eastern Province, Rwanda. PLoS neglected tropical diseases. 17(11). e0011768–e0011768. 3 indexed citations
4.
MacDonald, Shannon E., Yuba Raj Paudel, Ellen Rafferty, et al.. (2022). Impact of the COVID-19 pandemic on vaccine coverage for early childhood vaccines in Alberta, Canada: a population-based retrospective cohort study. BMJ Open. 12(1). e055968–e055968. 32 indexed citations
5.
Vilches, Thomas N., Ellen Rafferty, Chad R. Wells, Alison P. Galvani, & Seyed M. Moghadas. (2022). Economic evaluation of COVID-19 rapid antigen screening programs in the workplace. BMC Medicine. 20(1). 452–452. 5 indexed citations
6.
Lunney, Meaghan, Paul E. Ronksley, Robert G. Weaver, et al.. (2021). COVID-19 infection among international travellers: a prospective analysis. BMJ Open. 11(6). e050667–e050667. 6 indexed citations
7.
Rafferty, Ellen, et al.. (2021). A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine. PharmacoEconomics. 39(9). 1059–1073. 23 indexed citations
8.
Rafferty, Ellen, et al.. (2020). What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model. Value in Health. 24(1). 50–60. 6 indexed citations
12.
Rafferty, Ellen, et al.. (2019). PIN75 WHAT WE KNOW NOW: REVISITING THE COST-EFFECTIVENESS OF CHICKENPOX VACCINATION USING AN AGENT-BASED MODEL. Value in Health. 22. S652–S652. 1 indexed citations
13.
Simmonds, Kimberley, et al.. (2018). Vaccine coverage of children in care of the child welfare system. Canadian Journal of Public Health. 110(1). 44–51. 9 indexed citations
14.
Rafferty, Ellen, et al.. (2018). Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling. PeerJ. 6. e5012–e5012. 14 indexed citations
15.
Rafferty, Ellen, Erin Hetherington, Suzanne Tough, et al.. (2018). The impact of time since vaccination and study design on validity in parental recall of childhood vaccination status in the All Our Families cohort. Vaccine. 36(21). 2953–2959. 6 indexed citations
16.
Rafferty, Ellen, et al.. (2018). Access to Medical Devices in Low-Income Countries: Addressing Sustainability Challenges in Medical Device Donations. NAM Perspectives. 8(7). 20 indexed citations
17.
Rafferty, Ellen, et al.. (2017). Economic evaluations of vaccines in Canada: a scoping review. Cost Effectiveness and Resource Allocation. 15(1). 7–7. 6 indexed citations
18.
Rafferty, Ellen, Mohsen Yaghoubi, Jeff Taylor, & Marwa Farag. (2017). Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan. Cost Effectiveness and Resource Allocation. 15(1). 3–3. 31 indexed citations
19.
Rafferty, Ellen, Janna M. Schurer, Michael B. Arndt, et al.. (2017). Pediatric cryptosporidiosis: An evaluation of health care and societal costs in Peru, Bangladesh and Kenya. PLoS ONE. 12(8). e0182820–e0182820. 4 indexed citations
20.
Rafferty, Ellen, Philippe Duclos, Sergio Yactayo, & Melanie Schuster. (2013). Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review. Vaccine. 31(49). 5798–5805. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026